Skip to main content

Table 1 Data extracted from "published series"

From: Safety of percutaneous aortic valve insertion. A systematic review

Reference

Time window

n

Age in years mean ± SD (median: IQR)

Logistic EuroSCORE mean ± SD (median: IQR)

STS score

Device, approach

Success rate (%)

30-d mort (%)

6-m mort (%)

[27]

Jan 2005 - July 2005

18

81 ± 6

26.2 ± 13.1

NA

Ed, TF

77.8

11.1

NA

[23]

Jan 2005 - NA

50

82 ± 7

28

NA

Ed, TF

86

12

18

[28]

Feb 2005 - Nov 2005

25

80.3 ± 5.4

(10.97:19.90-9.20)

NA

CV, TF

84

20

NA

[29]

March 2005 - Aug 2006

11

81.8 ± 6.8

(36: 5-48)

NA

CV, TF

100

18.2

NA

[30]

Aug 2005 - Feb 2007

86

82.2 ± 5.9

21.7 ± 12.6

NA

CV, TF

88

12

NA

[31]

Oct 2005 - NA

7

63-91

range: 7-66

NA

Ed, TA

100

14.3

42.8

[32]§

Oct 2005 - NA

7

63-91

range: 7-66

NA

Ed, TA

§

§

§

[33]

Dec 2005 - Aug 2006

10

(81.3: 64-85)

(32: 21-40)

NA

CV, TF

100

20

NA

[34]

Feb 2006 - Sep 2006

30

82 ± 5

27.1 ± 12.2

NA

Ed, TA

96.6

6.6

NA

[35]

Feb 2006 - March 2007

50

82.4 ± 4.6

276 ± 12.2

15.8 ± 9.1

Ed, TA

94

8

26.1

[21]

Feb 2006 - Oct 2006

59

81.4 ± 5.8

26.8 ± 13.5

NA

Ed, TA

93.2

13.6

NA

[36]

Feb 2006 - Feb 2008

26

84 ± 7

36.5 ± 5.8

NA

Ed, TA

100

15

NA

[37]

Oct 2006 - Apr 2007

12

85 ± 6

31.1 ± 14.4

18.8 ± 4.3

Ed, TF

83

25

25

[14]

Dec 2006 - Feb 2008

40

83 ± 7.5

35.5 ± 15.3

13.4

Ed, TA

87.5

17.5

41.3

[38]

April 2007 - January 2008

22

84 ± 7

26 ± 16*

 

Ed, TF+TA

91

9.1

NA

  1. NA: not available. Ed: Edwards Lifesciences device (or any of its predecessors). CV: CoreValve Revalving System. TF: transfemoral. TA: transapical. § 6-month follow-up of data from [31] *: risk estimation tool not mentioned. SD: standard deviation. IRQ: interquartile range. NA: not available. Success: % of attempted successful. STS: Society of Thoracic Surgeons.